Abstract
212. Phase I Trial of Intratumoral (IT) Administration of HF10, a Replication-Competent Herpes Simplex Virus Type 1, in Patients with Refractory Superficial Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have